Researchers based in Germany have developed a perfusion process for the manufacture of oncolytic viruses. The team from the Max Planck Institute says that the new approach aims to improve virus titers ...
Brown joined Charles River in November 2022 after completing his bachelor’s degree from the University of Scranton. Brown started his journey in the Viral Clearance Department at the Wayne, PA site as ...
Oncolytic viruses, including the measles virus (MeV), exhibit a preferential ability to kill cancer cells, making them promising candidates for novel tumor therapies. As part of their infection cycle, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results